Literature DB >> 11855973

The most common chemical replacements in drug-like compounds.

Robert P Sheridan1.   

Abstract

We have written a method that extracts one-to-one replacements of chemical groups in pairs of drug-like molecules with the same biological activity and counts the frequency of the replacements in a large collection of such molecules. There are two variations on the method that differ in their treatment of replacements in rings. This method is one possible approach to systematically identify candidate bioisosteres. Here we look at the MDDR database because it has a large diversity of drug-like compounds in a large number of therapeutic areas. The most frequent replacements in MDDR seem generally consistent with medicinal chemistry intuition about what chemical groups are equivalent or with groups that are easily converted by synthetic or metabolic pathways. This method can be applied to any set of molecules wherein the molecules can be paired by similar biological activity.

Mesh:

Year:  2002        PMID: 11855973     DOI: 10.1021/ci0100806

Source DB:  PubMed          Journal:  J Chem Inf Comput Sci        ISSN: 0095-2338


  19 in total

1.  Successful identification of key chemical structure modifications that lead to improved ADME profiles.

Authors:  Lourdes Cucurull-Sanchez
Journal:  J Comput Aided Mol Des       Date:  2010-05-09       Impact factor: 3.686

2.  Identification of target-specific bioisosteric fragments from ligand-protein crystallographic data.

Authors:  Elizabeth A Kennewell; Peter Willett; Pierre Ducrot; Claude Luttmann
Journal:  J Comput Aided Mol Des       Date:  2006-10-13       Impact factor: 3.686

3.  Automated molecule editing in molecular design.

Authors:  Peter W Kenny; Carlos A Montanari; Igor M Prokopczyk; Fernanda A Sala; Geraldo Rodrigues Sartori
Journal:  J Comput Aided Mol Des       Date:  2013-09-04       Impact factor: 3.686

4.  Herman Skolnik award symposium honoring Yvonne Martin.

Authors:  Wendy A Warr
Journal:  J Comput Aided Mol Des       Date:  2009-12-10       Impact factor: 3.686

5.  A new class of orthosteric uPAR·uPA small-molecule antagonists are allosteric inhibitors of the uPAR·vitronectin interaction.

Authors:  Degang Liu; Donghui Zhou; Bo Wang; William Eric Knabe; Samy O Meroueh
Journal:  ACS Chem Biol       Date:  2015-03-31       Impact factor: 5.100

6.  Activity of an antimicrobial peptide mimetic against planktonic and biofilm cultures of oral pathogens.

Authors:  Nicholas Beckloff; Danielle Laube; Tammy Castro; David Furgang; Steven Park; David Perlin; Dylan Clements; Haizhong Tang; Richard W Scott; Gregory N Tew; Gill Diamond
Journal:  Antimicrob Agents Chemother       Date:  2007-09-04       Impact factor: 5.191

7.  A small-molecule inhibitor of the ribonucleolytic activity of human angiogenin that possesses antitumor activity.

Authors:  Richard Y T Kao; Jeremy L Jenkins; Karen A Olson; Marc E Key; James W Fett; Robert Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-12       Impact factor: 11.205

8.  Minimal pharmacophoric elements and fragment hopping, an approach directed at molecular diversity and isozyme selectivity. Design of selective neuronal nitric oxide synthase inhibitors.

Authors:  Haitao Ji; Benjamin Z Stanton; Jotaro Igarashi; Huiying Li; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  J Am Chem Soc       Date:  2008-03-06       Impact factor: 15.419

9.  SCRIPDB: a portal for easy access to syntheses, chemicals and reactions in patents.

Authors:  Abraham Heifets; Igor Jurisica
Journal:  Nucleic Acids Res       Date:  2011-11-08       Impact factor: 16.971

10.  Theoretical prediction of hydrogen-bond basicity pKBHX using quantum chemical topology descriptors.

Authors:  Anthony J Green; Paul L A Popelier
Journal:  J Chem Inf Model       Date:  2014-02-04       Impact factor: 4.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.